Colgate-Palmolive Company (CL) has seen a mixed bag of events recently. The company has been recognized by UBS for their potential in the AI, growth, and low rates era. This was offset by underperformance compared to competitors on certain days. In institutional activity, Principal Financial Group and several other firms increased holdings while M&G Plc and Fiera Capital Corp reduced positions. The recent selling of shares by an insider also created a stir. Despite a 3.35% decrease on November 6, there were moments of positivity like an overhaul in outlook after Q3 earnings, which reflected market share gains and margin expansion. The company rewards investors with a 10% CAGR over the last five years, suggesting consistent growth. The substantial institutional backing, owning 84% of the company, provides a degree of assurance to stakeholders. Despite disappointing North American sales, the company beat Q3 earnings estimates with the aid of a strong product demand. Even though the stock is valued at a PE ratio of 26.74, some analysts estimate it to be 31% undervalued, implying a potentially lucrative opportunity.
Colgate-Palmolive Company CL News Analytics from Thu, 28 Mar 2024 07:00:00 GMT to Sat, 09 Nov 2024 20:54:00 GMT -
Rating 4
- Innovation -2
- Information 6
- Rumor -3
